Upgrade to SI Premium - Free Trial

Emergent BioSolutions (EBS)

8.07 -0.37 (4.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose June 4, 2026 8:02 AM - StreetInsider Benchmark Reiterates Buy Rating on Emergent BioSolutions (EBS) June 2, 2026 8:40 AM - StreetInsider Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy May 28, 2026 4:01 PM - StreetInsider Emergent BioSolutions to Participate in Upcoming Investor Conferences May 20, 2026 7:30 AM - Globe NewsWire Emergent BioSolutions gets Saudi approval for smallpox, mpox vaccine May 18, 2026 9:00 AM - StreetInsider Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live] May 18, 2026 8:59 AM - Globe NewsWire Form 4 Emergent BioSolutions For: Apr 30 Filed by: Dayal Sujata Tyagi May 4, 2026 5:31 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: DeGolyer Donald W May 4, 2026 5:30 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Katkin Keith May 4, 2026 5:30 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: White Marvin L May 4, 2026 5:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: FOWLER JOHN D JR May 4, 2026 5:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Richard Ronald May 4, 2026 5:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Zoon Kathryn C May 4, 2026 5:28 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Fowler Neal Franklin May 4, 2026 5:28 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Harsanyi Zsolt May 4, 2026 5:24 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Williams Paul Anthony May 1, 2026 4:30 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Lowry Simon C May 1, 2026 4:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Glessner Coleen May 1, 2026 4:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: LINDAHL RICHARD S May 1, 2026 4:28 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Perl Jessica May 1, 2026 4:27 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Hartzel William May 1, 2026 4:27 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: PAPA JOSEPH C May 1, 2026 4:26 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: Dayal Sujata Tyagi May 1, 2026 4:21 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: Zoon Kathryn C May 1, 2026 4:03 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: DeGolyer Donald W May 1, 2026 4:03 PM - SEC Filing Form 10-Q Emergent BioSolutions For: Mar 31 May 1, 2026 9:34 AM - SEC Filing Emergent BioSolutions (EBS) Misses Q1 EPS by 65c May 1, 2026 2:02 AM - StreetInsider Form S-8 Emergent BioSolutions April 30, 2026 4:43 PM - SEC Filing Form 8-K Emergent BioSolutions For: Apr 30 April 30, 2026 4:35 PM - SEC Filing Emergent BioSolutions Reports First Quarter 2026 Financial Results April 30, 2026 4:30 PM - StreetInsider Form 144 Emergent BioSolutions Filed by: Katkin Keith April 30, 2026 4:16 PM - SEC Filing Emergent BioSolutions gains Singapore approval for ACAM2000 mpox indication April 30, 2026 7:55 AM - StreetInsider Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox April 30, 2026 7:55 AM - Globe NewsWire Form 8-K Emergent BioSolutions For: Apr 29 April 30, 2026 7:31 AM - SEC Filing Form SCHEDULE 13G Emergent BioSolutions Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 6:27 PM - SEC Filing Emergent BioSolutions signs $50 million manufacturing deal with SAB BIO April 29, 2026 7:35 AM - StreetInsider Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142 April 29, 2026 7:35 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS) April 29, 2026 7:25 AM - StreetInsider Emergent BioSolutions partners with baseball player Davis Schneider for opioid awareness April 29, 2026 6:54 AM - StreetInsider Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives April 29, 2026 6:53 AM - Globe NewsWire Form DEFA14A Emergent BioSolutions April 28, 2026 3:09 PM - SEC Filing Emergent BioSolutions partners with Substipharm for JE vaccine manufacturing April 28, 2026 8:01 AM - StreetInsider Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States April 28, 2026 8:01 AM - StreetInsider Form DEFA14A Emergent BioSolutions April 27, 2026 4:55 PM - SEC Filing Form DEFA14A Emergent BioSolutions April 22, 2026 4:50 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS) April 20, 2026 6:40 AM - StreetInsider Form 8-K Emergent BioSolutions For: Apr 16 April 17, 2026 6:04 AM - SEC Filing Emergent BioSolutions refinances debt, extends maturities to 2031 April 16, 2026 4:06 PM - StreetInsider Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026 April 16, 2026 4:05 PM - StreetInsider Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility April 16, 2026 4:05 PM - StreetInsider Form DEFA14A Emergent BioSolutions April 16, 2026 9:33 AM - SEC Filing Form DEFA14A Emergent BioSolutions April 16, 2026 9:31 AM - SEC Filing Emergent BioSolutions partners with British Columbia for naloxone program April 9, 2026 4:25 PM - StreetInsider Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program April 9, 2026 4:25 PM - StreetInsider Form SCHEDULE 13G Emergent BioSolutions Filed by: DIMENSIONAL FUND ADVISORS LP April 9, 2026 1:43 PM - SEC Filing Emergent BioSolutions launches NARCAN carrying case and multipacks April 7, 2026 12:42 PM - StreetInsider Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness April 7, 2026 12:41 PM - Globe NewsWire Form 4 Emergent BioSolutions For: Apr 01 Filed by: Williams Paul Anthony April 3, 2026 4:06 PM - SEC Filing Emergent BioSolutions Participates in Upcoming International Preparedness Conferences April 2, 2026 8:00 AM - StreetInsider Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony April 1, 2026 4:07 PM - SEC Filing Form SCHEDULE 13G/A Emergent BioSolutions Filed by: VANGUARD GROUP INC March 26, 2026 6:03 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS) March 26, 2026 6:45 AM - StreetInsider Emergent BioSolutions secures $60.6 million in smallpox countermeasure contracts March 25, 2026 4:15 PM - StreetInsider Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures March 25, 2026 4:15 PM - StreetInsider Form ARS Emergent BioSolutions For: Dec 31 March 20, 2026 4:55 PM - SEC Filing Form DEFA14A Emergent BioSolutions March 20, 2026 4:53 PM - SEC Filing Form DEF 14A Emergent BioSolutions For: Dec 31 March 20, 2026 4:51 PM - SEC Filing Emergent BioSolutions (EBS) PT Lowered to $12 at H.C. Wainwright March 9, 2026 6:50 AM - StreetInsider Full Article List